Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
Shanti Amé(Institut de Cancérologie Strasbourg), Jean‐Jacques Kiladjian(Délégation Paris 5), Éric Jourdan(Université de Nîmes), Fiorenza Barraco(Hôpital Lyon Sud), Mathieu Wémeau(Inserm), Jean‐François Viallard(Université de Bordeaux), Jérôme Rey, Jean‐Christophe Ianotto(Inserm)
Cited by 6
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862